Differential effects of the Affordable Care Act on the stage at presentation and receipt of treatment for pancreatic adenocarcinoma

For pancreatic ductal adenocarcinoma (PDAC) which lacks a recommended screening modality, the benefit of the Affordable Care Act (ACA) may not be an earlier diagnosis, but rather improved rates of treatment. The objective of this study was to examine change in the stage of PDAC presentation and treatment disparities following the ACA.

• Publication year

  2022

• Venue

  Journal of Surgical Oncology

• Publication date

  2022-06-14

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1002/jso.26984PMID 35699593
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disparities in Stage-Specific Guideline-Concordant Cancer-Directed Treatment for Patients with Pancreatic Adenocarcinoma

  2021cited by this paper
• Cancer Statistics, 2021

  2021cited by this paper
• Race, Age, Gender, and Insurance Status: A Comparative Analysis of Access to and Quality of Gastrointestinal Cancer Care

  2021influential reference
• Changes in the Proportion of Patients Presenting With Early Stage Colon Cancer Over Time Among Medicaid Expansion and Nonexpansion States: A Cross-sectional Study

  2021cited by this paper
• Thirty‐day complication rates do not differ by race among patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma

  2021cited by this paper
• Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.

  2020cited by this paper
• Early detection of pancreatic cancer.

  2020cited by this paper
• Recent trends in the incidence and survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results analysis.

  2020cited by this paper
• Impact of the Affordable Care Act on Colorectal Cancer Outcomes: A Systematic Review.

  2020cited by this paper
• Stratifying Intraductal Papillary Mucinous Neoplasms by Cyst Fluid Analysis: Present and Future

  2020cited by this paper
• The Affordable Care Act's Medicaid Expansion and Impact along the Cancer-Care Continuum: A Systematic Review.

  2020cited by this paper
• Insurance Status as a Surrogate for Social Determinants of Health in Cancer Clinical Trials.

  2020cited by this paper
• Sociodemographic Disparities in the Receipt of Adjuvant Chemotherapy Among Patients With Resected Stage I-III Pancreatic Adenocarcinoma.

  2019cited by this paper
• Disparities in the Use of Chemotherapy in Patients with Resected Pancreatic Ductal Adenocarcinoma

  2019cited by this paper
• Understanding and addressing social determinants to advance cancer health equity in the United States: A blueprint for practice, research, and policy

  2019cited by this paper
• Disparities in Pancreatic Cancer Treatment and Outcomes

  2019influential reference
• Impact of the Affordable Care Act on Colorectal Cancer Screening, Incidence, and Survival in Kentucky.

  2019cited by this paper
• Cervical and colorectal cancer screening prevalence before and after Affordable Care Act Medicaid expansion.

  2019cited by this paper
• Low rates of specialized cancer consultation and cancer-directed therapy for noncurable pancreatic adenocarcinoma: a population-based analysis

  2019cited by this paper
• Early Detection of Pancreatic Cancer

  2018cited by this paper
• Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update.

  2018cited by this paper
• Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer

  2018influential reference
• Equivalent Treatment and Survival after Resection of Pancreatic Cancer at Safety-Net Hospitals

  2017cited by this paper
• Changes in Insurance Coverage and Stage at Diagnosis Among Nonelderly Patients With Cancer After the Affordable Care Act.

  2017cited by this paper
• Barriers to Care and Health Care Utilization Among the Publicly Insured

  2017cited by this paper
• Early detection of pancreatic cancer: Where are we now and where are we going?

  2017cited by this paper
• Patient Experience Of Provider Refusal Of Medicaid Coverage And Its Implications

  2016cited by this paper
• The Affordable Care Act’s Impacts on Access to Insurance and Health Care for Low-Income Populations

  2016influential reference
• Pancreatic Cancer Disparities in African Americans

  2015influential reference
• A cost analysis of a pancreatic cancer screening protocol in high-risk populations.

  2015cited by this paper
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.

  2014cited by this paper
• AFFORDABLE CARE ACT

  2012cited by this paper
• FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

  2011cited by this paper
• Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies

  2007cited by this paper
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

  2007cited by this paper
• Cancer statistics

  1989cited by this paper

• Race norming and biases in surgical oncology care

  2024cites this paper
• Impact of Medicaid Expansion on Screenable versus Non-Screenable Gastrointestinal Cancers.

  2024cites this paper
• Longitudinal assessment of disparities in pancreatic cancer care: A retrospective analysis of the National Cancer Database.

  2024cites this paper
• Impact of the Affordable Care Act on Presentation, Treatment, and Outcomes of Intrahepatic Cholangiocarcinoma

  2022cites this paper